8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2016 / Multicenter randomized controlled trial
Healthy, non-obese participants were randomized 2:1 to 25% caloric restriction or an ad-libitum diet for two years. Overall adverse event rates did not differ significantly between arms, with zero deaths and one serious adverse event reported during caloric restriction. However, participants assigned to caloric restriction developed significantly lower bone mineral density at the lumbar spine, total hip, and femoral neck at 12 and 24 months.
Romashkan SV, Das SK, Villareal DT, et al. Oncotarget, 2016. PMID 26992237
2016 / Double-blind, placebo-controlled randomized clinical trial
A total of 417 elderly patients with an acute distal radius fracture were randomized to receive skimmed milk containing either Lactobacillus casei Shirota or placebo daily for 6 months. Throughout the study, patients receiving probiotics showed a significantly faster pace of improvement in DASH score, pain, CRPS score, wrist flexion, and grip strength compared to placebo. Treatment outcomes for the probiotic group at month 4 were comparable to levels seen in the placebo group at month 6.
Lei M, Hua LM, Wang DW Benef Microbes, 2016. PMID 27633174
2016 / Randomized controlled trial
Forty-five women aged 63-79 years with osteopenia or osteoporosis were randomly assigned to 12 weeks of Nordic walking training (3 times a week) or a control group. The training group showed significant increases in skeletal muscle mass (P=0.007), skeletal muscle index (P=0.007), knee extensor strength index (P=0.016), knee flexor strength index (P<0.001), functional mobility (P<0.001), and functional performance (P<0.001). Body mass (P=0.006), BMI (P<0.001), and percent body fat (P<0.001) significantly decreased, while handgrip strength showed no improvement (P=0.315). No significant changes occurred in the control group.
Ossowski ZM, Skrobot W, Aschenbrenner P, et al. Clin Interv Aging, 2016. PMID 27942207
2015 / Double-blind randomised placebo-controlled clinical trial
A 2-year trial randomized 605 participants with knee osteoarthritis to once-daily glucosamine sulfate (1500 mg), chondroitin sulfate (800 mg), both supplements, or placebo. After adjusting for structural disease progression factors, the combination group showed a statistically significant reduction in 2-year JSN versus placebo (mean difference 0.10 mm, 95% CI 0.002 mm to 0.20 mm; p=0.046), whereas single treatments showed no significant structural effect. All four groups had reduced knee pain over the first year, with no significant between-group differences (p=0.93). Overall, 34 (6%) participants reported possibly-related adverse medical events over 2 years.
Fransen M, Agaliotis M, Nairn L, et al. Ann Rheum Dis, 2015. PMID 24395557
2015 / Randomized controlled trial
In a 2-year randomized trial of 409 older women, neither 800 IU daily vitamin D nor exercise reduced overall fall rates (118.2 to 132.1 falls per 100 person-years across groups). However, injurious fall rates were significantly lower with exercise plus vitamin D (hazard ratio 0.38; 95% CI, 0.17-0.83) and exercise alone (hazard ratio 0.47; 95% CI, 0.23-0.99). Vitamin D maintained bone density, but only exercise enhanced physical functioning.
Uusi-Rasi K, Patil R, Karinkanta S, et al. JAMA Intern Med, 2015. PMID 25799402
2015 / 6-week prospective randomized open-label study
Forty participants aged 19-70 with osteoarthritis were randomized to a whole-foods, plant-based (WFPB) diet or their current diet for six weeks, with 37 completing the study. The intervention group reported significantly greater improvements than controls in SF-36v2 energy/vitality, physical functioning, role physical, and the physical component summary scale. Differences in PGIC scales were statistically significant over time, and improvement in weekly mean VAS pain was significantly greater in the intervention group from week 2 onward.
Clinton CM, O'Brien S, Law J, et al. Arthritis, 2015. PMID 25815212
2015 / Randomized controlled trial
Healthy post-menopausal women were randomized to consume ≥9 servings of a generic range of produce (Group A), specific produce with bone resorption-inhibiting properties (Group B), or their usual diet (Group C) for three months. Procollagen type I N propeptide (PINP) decreased significantly only in Group B (-3.2 μg/L, p < 0.01), and C-terminal telopeptide of type I collagen (CTX) decreased (-0.065 μg/L, p < 0.01) in osteopenic women compared to those with normal bone mineral density within Group B. Both Groups A and B showed decreased PRAL, increased urine pH, and significantly decreased urinary calcium loss.
Gunn CA, Weber JL, McGill AT, et al. Nutrients, 2015. PMID 25856221
2015 / Randomized controlled trial
In a randomized trial, 50 patients with knee osteoarthritis received either 40 grams daily of sesame seeds or placebo powder for two months alongside standard therapy. Interleukin-6 decreased significantly more in the sesame group than in controls (P = 0.001). Although malondialdehyde and high-sensitivity C-reactive protein dropped within the sesame group (P < 0.05), post-treatment levels of these markers and total antioxidant capacity did not differ significantly between groups.
Khadem Haghighian M, Alipoor B, Malek Mahdavi A, et al. Acta Med Iran, 2015. PMID 25871017
2015 / 5-year register-based follow-up of a 1-year randomized controlled trial
This 5-year register-based follow-up evaluated 145 older women who completed a 1-year, four-arm randomized controlled trial of exercise. Over follow-up, 81 injurious falls including 26 fractures occurred. Compared with controls, the combined resistance and balance-jumping exercise (COMB) group had a 62% lower rate of injured fallers (HR 0.38, 95% CI 0.17 to 0.85), 51% fewer injurious falls (RR 0.49, 95% CI 0.25 to 0.98), and 74% fewer fractures (RR 0.26, 95% CI 0.07 to 0.97). The authors note these long-term effects need to be confirmed in future studies.
Karinkanta S, Kannus P, Uusi-Rasi K, et al. Age Ageing, 2015. PMID 25990940
2015 / Randomized controlled trial
Postmenopausal osteopenic women were randomized to receive 1 g/d of creatine (n = 56) or dextrose placebo (n = 53) for one year. Bone mineral density at the spine, hip sites, and total skeleton showed no significant differences between or within treatment arms. Similarly, creatine did not significantly change body composition, lean mass, timed-up-and-go performance, or timed-stands test scores.
Lobo DM, Tritto AC, da Silva LR, et al. Exp Gerontol, 2015. PMID 26192975
2015 / Randomized controlled trial (Phase III)
A phase III randomized trial evaluated 201 JIA patients assigned to etanercept alone (50 mg twice weekly), etanercept plus 50 ml blueberry juice daily (ETABJ), or etanercept plus placebo juice (ETAPJ). After a 6-month follow-up, ACR20, ACR50, and ACR70 scores were significantly higher in the ETABJ group than in the other two groups (P < 0.05). Symptoms and side effects—including mental diseases, optic neuritis, weight gain, infection, cutaneous vasculitis, diarrhea, uveitis, and pancytopenia—were significantly reduced or absent in the ETABJ group. Blueberries also decreased IL-1 alpha and beta levels while increasing IL1RA levels.
Zhong Y, Wang Y, Guo J, et al. Tohoku J Exp Med, 2015. PMID 26477692
2015 / Controlled trial with four parallel groups
Forty male volunteers were divided into four equal groups: active controls, hypokinetic subjects (HKS), periodic fluid redistribution controls (PFRCS), and periodic fluid redistribution hypokinetic subjects (PFRHS). Bone density was measured over a 390-day pre-experimental and a 360-day experimental period. Bone density at lumbar vertebrae (L1-L4), ulna and radius, tarsal and metatarsal, and tibia and fibula increased (p<0.05) in the PFRHS group compared to the HKS group, whereas it decreased (p<0.05) in the HKS group compared to pre-experimental levels and other groups. Bone density improvements in the PFRCS group were much less than in the PFRHS group, while active controls showed no change.
Federenko YF, Charapakhin KP, Yaroshenko YN, et al. Indian J Physiol Pharmacol, 2015. PMID 26571991
2014 / Randomized controlled trial
Osteopenic postmenopausal women (n=160) were randomized to consume either 100 g dried plum/d or 75 g dried apple/d for 1 year, with all participants receiving daily calcium (500 mg) and vitamin D (400 IU). Dried plum significantly increased the BMD of the ulna and spine compared with the dried apple control group. Compared to baseline, dried plum changed RANKL (+1.99% vs. +18.33%), OPG (+4.87% vs. -2.15%), and sclerostin (-1.12% vs. +3.78%) relative to control, though these biomarker percentage changes did not reach statistical significance (P <= 0.05).
Hooshmand S, Brisco JR, Arjmandi BH Br J Nutr, 2014. PMID 24780728
2014 / Open-label clinical pilot study
An open-label pilot study evaluated the effects of consuming 4.25 g of dried apple peel powder (DAPP) daily for 12 weeks in 12 healthy subjects with moderate loss of joint range of motion and chronic pain. Consumption of DAPP for 12 weeks was associated with improved ROM, pain reduction, and a statistically significant improvement in serum antioxidant protective status. In vitro assays demonstrated that DAPP inhibited COX-2 and lipoxygenase enzymes and reduced ROS formation in inflammatory polymorphonuclear cells.
Jensen GS, Attridge VL, Benson KF, et al. J Med Food, 2014. PMID 25271471
2014 / Randomized controlled trial
In a randomized trial of 670 pregnant Mexican women, taking 1,200 mg per day of calcium reduced urinary N-telopeptides by 15.8% compared to placebo (p < 0.001). Greater pill compliance led to larger reductions in bone resorption up to 22.1% (p < 0.001). Calcium also produced a lower ratio of bone resorption to formation at one month postpartum (p = 0.04).
Ettinger AS, Lamadrid-Figueroa H, Mercado-García A, et al. Nutr J, 2014. PMID 25511814
2013 / Randomized, double-blind, placebo-controlled trial
In a randomized, double-blind, placebo-controlled trial, 201 healthy older adults without osteoporosis were assigned to 60 mEq of oral potassium citrate daily or placebo for 24 months alongside calcium and vitamin D. Potassium citrate increased lumbar spine areal BMD from baseline by 1.7 ± 1.5% net of placebo (95% CI 1.0-2.3, P < 0.001). Trabecular densities also increased at the nondominant tibia (1.3 ± 1.3%, P < 0.001) and nondominant radius (2.0 ± 2.0%, P < 0.001), alongside improvements in trabecular bone volume/tissue volume (0.9 ± 0.8%), thickness (1.5 ± 1.6%), and number (1.9 ± 1.8%, all P < 0.05). Potassium citrate also significantly decreased FRAX fracture prediction scores in both sexes.
Jehle S, Hulter HN, Krapf R J Clin Endocrinol Metab, 2013. PMID 23162100
2013 / Randomized crossover trial
In a randomized crossover trial, 58 individuals with knee osteoarthritis drank two 8 oz bottles of tart cherry juice or placebo daily for 6 weeks, separated by a 1-week washout. WOMAC scores decreased significantly following cherry juice intake (P < 0.01) but not placebo (P = 0.46), though the difference between treatments was not significant (P = 0.16). Cherry juice lowered hsCRP relative to placebo (P < 0.01), but walking time and acetaminophen use did not differ between treatments.
Schumacher HR, Pullman-Mooar S, Gupta SR, et al. Osteoarthritis Cartilage, 2013. PMID 23727631
2013 / Randomized controlled trial follow-up
In a follow-up of a randomized trial, 68 rural Gambian women with low calcium intake were evaluated approximately 5 years after lactation. Placebo recipients showed increased size-adjusted bone mineral content (SA-BMC) when non-pregnant and non-lactating (NPNL, P <= 0.001), whereas calcium recipients (1500 mg/d in pregnancy) did not. Lower SA-BMC persisted in the calcium group at NPNL (lumbar spine, -7.5%; total hip, -10.5%; whole body, -3.6%) and in a future lactation (all P <= 0.001).
Jarjou LM, Sawo Y, Goldberg GR, et al. Am J Clin Nutr, 2013. PMID 23902782
2012 / Cluster randomized controlled trial
A cluster randomized trial across 51 care facilities assigned 602 older adults (mean age 86.4 years) to daily early-morning sunlight, sunlight with calcium (600 mg/day), or control for one year. Overall adherence was low at a median of 26%, and intention-to-treat analysis showed no effect on fall risk (IRR 1.06; 95% CI, 0.76-1.48; P = 0.73). However, attending at least 130 sunlight sessions was linked to significantly fewer falls (IRR 0.52; 95% CI, 0.31-0.88).
Sambrook PN, Cameron ID, Chen JS, et al. Osteoporos Int, 2012. PMID 21369788
2012 / Randomized controlled trial
A randomized trial assigned 120 elderly participants (mean age 70.1 years) to 300,000 IU of vitamin D or placebo administered orally or intramuscularly. At four weeks, both routes of vitamin D significantly reduced parathyroid hormone (P = 0.0001) and raised vitamin D levels (P = 0.0001 for injection, P = 0.004 for oral). Both treated groups showed significant reductions in pain scores, improved mobility, and enhanced physical functioning.
Sakalli H, Arslan D, Yucel AE Rheumatol Int, 2012. PMID 21556746
2012 / Randomized double-blind crossover trial and open-label extension
In a randomized, double-blind crossover study with 36 patients, participants received a 4g dose of curcumin or placebo for 3 months before crossing over, followed by an optional 8g open-label extension. Curcumin treatment decreased the free light-chain ratio and reduced the difference between clonal and nonclonal light chains. Urine DPYD, representing bone resorption, decreased with curcumin but rose with placebo, while serum creatinine tended to drop.
Golombick T, Diamond TH, Manoharan A, et al. Am J Hematol, 2012. PMID 22473809
2012 / Crossover trial
Seven healthy young males completed two 3-week periods of head-down bed rest, receiving 90 mmol potassium bicarbonate daily as a nutritional countermeasure in a crossover design. In one bed rest period, a significant decrease in IL-2, IFN-γ, and TNF-α production occurred after PHA stimulation, leading to a relative Th2-shift before rapid normalization. Dietary supplementation with potassium bicarbonate counteracted the decrease in IL-2 levels during bed rest, but showed no impact on other immunological parameters.
Kelsen J, Bartels LE, Dige A, et al. Cytokine, 2012. PMID 22595648
2012 / Randomized controlled trial
In a randomized controlled study, 43 patients with knee and hip osteoarthritis received either 340 mg daily of a ginger extract (n=21) or 100 mg daily of diclofenac (n=22) for 4 weeks, with both groups also receiving 1000 mg glucosamine daily. Both groups showed significantly lowered arthritic pain on standing and moving measured by VAS. The ginger group experienced slightly but significantly lowered SODA pain, no change in SODA dyspepsia, and significantly increased stomach mucosa levels of PGE1, PGE2, and PGF2α. In contrast, the diclofenac group showed increased SODA pain and dyspepsia, along with decreased mucosal prostaglandins and negative stomach mucosa degeneration.
Drozdov VN, Kim VA, Tkachenko EV, et al. J Altern Complement Med, 2012. PMID 22784345
2011 / Randomized controlled trial
Sixty postmenopausal women underwent a 1-month washout and were then randomized to regular tomato juice (30 mg lycopene/day), lycopene-rich tomato juice (70 mg/day), Lyc-O-Mato capsules (30 mg/day), or placebo capsules for 4 months. Participants receiving tomato juice or lycopene capsules were analyzed together as a lycopene-supplemented group. Compared to placebo, 4 months of lycopene supplementation significantly increased serum lycopene (p < 0.001) and total antioxidant capacity (p < 0.05). Lycopene also led to significant reductions in lipid peroxidation (p < 0.05 vs placebo change), protein oxidation (p < 0.005 vs placebo change), and the bone resorption marker NTx (p < 0.02 vs placebo change).
Mackinnon ES, Rao AV, Josse RG, et al. Osteoporos Int, 2011. PMID 20552330